The World Health Organisation’s (WHO) has announced the inclusion of rapid-acting insulin analogues and GLP-1 receptor ...

What may seem like a technical exercise in global health bureaucracy- the World Health Organization’s update to its Essential ...

Adherence to an app-based insulin dosing guide was associated with improved self-measured blood glucose among patients with type 2 diabetes.

The CDSCO's expert panel consented for firm's proposal for discontinuation of products noting that alternative therapies are ...

Childhood type 2 diabetes that was rare is now on rise alarmingly in India possibly due to obesity, lifestyle changes and ...

The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list alongside treatments ...

The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list alongside treatments ...

DETROIT – Despite advances in insulin therapy and automated delivery systems, people with Type 1 diabetes (T1D) still face a daily struggle: manually dosing insulin before meals. Current insulin ...

WHO adds GLP-1 diabetes drugs to its Essential Medicines List. Indian pharma firms prepare to launch generics as patents ...

WHO has updated its Essential Medicines Lists, adding new cancer, diabetes, obesity, and cystic fibrosis treatments, aiming to improve global access, reduce costs, and provide life-saving care for ...

European Association for the Study of Diabetes Opens on September 15Simpler and More Potent... The Race to Develop Obesity ...

The competition to develop obesity treatments that are more convenient and powerful than Wegovy and Mounjaro is intensifying. Since the popularization ...